- Home
- AVAH vs TNGX Comparison
AVAH vs TNGX Comparison
Compare AVAH & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAH
- TNGX
- Stock Information
- Founded
- AVAH 1984
- TNGX 2014
- Country
- AVAH United States
- TNGX United States
- Employees
- AVAH N/A
- TNGX N/A
- Industry
- AVAH Hospital/Nursing Management
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- AVAH Health Care
- TNGX Health Care
- Exchange
- AVAH Nasdaq
- TNGX Nasdaq
- Market Cap
- AVAH 872.6M
- TNGX 723.0M
- IPO Year
- AVAH 2021
- TNGX N/A
- Fundamental
- Price
- AVAH $3.74
- TNGX $6.53
- Analyst Decision
- AVAH Hold
- TNGX Strong Buy
- Analyst Count
- AVAH 6
- TNGX 5
- Target Price
- AVAH $5.25
- TNGX $10.50
- AVG Volume (30 Days)
- AVAH 396.7K
- TNGX 1.9M
- Earning Date
- AVAH 08-07-2025
- TNGX 08-05-2025
- Dividend Yield
- AVAH N/A
- TNGX N/A
- EPS Growth
- AVAH N/A
- TNGX N/A
- EPS
- AVAH 0.03
- TNGX N/A
- Revenue
- AVAH $2,093,077,000.00
- TNGX $40,990,000.00
- Revenue This Year
- AVAH $9.80
- TNGX N/A
- Revenue Next Year
- AVAH $4.77
- TNGX N/A
- P/E Ratio
- AVAH $141.32
- TNGX N/A
- Revenue Growth
- AVAH 9.05
- TNGX 10.09
- 52 Week Low
- AVAH $2.61
- TNGX $1.03
- 52 Week High
- AVAH $6.19
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- AVAH 28.86
- TNGX 60.33
- Support Level
- AVAH $3.88
- TNGX $6.36
- Resistance Level
- AVAH $4.08
- TNGX $7.11
- Average True Range (ATR)
- AVAH 0.15
- TNGX 0.52
- MACD
- AVAH 0.02
- TNGX -0.13
- Stochastic Oscillator
- AVAH 1.61
- TNGX 53.15
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.